Synthomer plc (LON:SYNT - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 205.61 ($2.52) and traded as low as GBX 132.80 ($1.63). Synthomer shares last traded at GBX 133 ($1.63), with a volume of 203,049 shares trading hands.
Analysts Set New Price Targets
SYNT has been the subject of several recent research reports. Canaccord Genuity Group lowered their target price on Synthomer from GBX 300 ($3.67) to GBX 275 ($3.37) and set a "buy" rating for the company in a report on Friday, October 4th. Berenberg Bank lowered their target price on Synthomer from GBX 265 ($3.24) to GBX 230 ($2.82) and set a "buy" rating for the company in a report on Monday, January 6th.
Check Out Our Latest Report on Synthomer
Synthomer Price Performance
The firm has a market capitalization of £229.65 million, a P/E ratio of -230.16, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The business has a fifty day moving average of GBX 162.35 and a 200-day moving average of GBX 204.79. The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90.
About Synthomer
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Featured Stories
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
